the simultaneous topical administration of dfmo and mgbg , allowing the use of lower concentrations of the more toxic mgbg , may be useful for therapy of psoriasis and other cutaneous disorders associated with abnormalities in polyamine metabolism .
C0033860
psoriasis
C0037274
cutaneous disorders